Alexion Pharmaceuticals downgraded to equal weight from overweight at Barclays Related posts: BRIEF-Hunter Douglas to acquire Levolor from Newell Rubbermaid JGBs firm, underpinned by Treasuries, BOJ operations Dow industrials drop 209 points to 17,719 Here Are The 5 Largest Companies In The US Right Now Post navigation EUR/GBP supported on key 20 DMA Alexion Pharmaceuticals stock price target cut to $205 from $220 at Barclays
